Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lenn Fechter"'
Autor:
Zhu Shen, Wenfei Du, Cecelia Perkins, Lenn Fechter, Vanita Natu, Holden Maecker, Jesse Rowley, Jason Gotlib, James Zehnder, Anandi Krishnan
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 10, Pp 100425- (2021)
Summary: Predicting disease progression remains a particularly challenging endeavor in chronic degenerative disorders and cancer, thus limiting early detection, risk stratification, and preventive interventions. Here, profiling the three chronic subt
Externí odkaz:
https://doaj.org/article/c4d0593a2b634f218289a7c2f4e8966d
Autor:
Sumanth Mosale Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden Maecker, Jason Gotlib, James Zehnder, Ramasamy Paulmurugan, Anandi Krishnan
Impaired protein homeostasis, though well established in age-related disorders, has been linked in recent research with the pathogenesis of myeloproliferative neoplasms (MPNs). As yet, however, little is known about MPN-specific modulators of proteos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29b38d5fcfe2f95daa0dbdb54e7f388c
https://doi.org/10.1101/2023.01.07.523111
https://doi.org/10.1101/2023.01.07.523111
Autor:
Emily Liang, Cecelia Perkins, Rong Lu, Hongliang Shi, Saša Dimitrijević, Gerard Hoehn, Justin Abuel, Cheryl Langford, Parveen Abidi, Lenn Fechter, William Shomali, Jason Gotlib
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22
Advanced SM (AdvSM) comprises 3 subtypes: aggressive SM (ASM), SM with an associated hematologic neoplasm (SM-AHN), and mast cell leukemia (MCL). The patterns of organ damage, which have been defined by WHO, IWG, and modified IWG (mIWG) criteria, acr
Autor:
Jesse W. Rowley, James L. Zehnder, Jason Gotlib, Vanita Natu, Anandi Krishnan, Cecelia Perkins, Wenfei Du, Zhu Shen, Holden T. Maecker, Lenn Fechter
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 10, Pp 100425-(2021)
Summary: Predicting disease progression remains a particularly challenging endeavor in chronic degenerative disorders and cancer, thus limiting early detection, risk stratification, and preventive interventions. Here, profiling the three chronic subt
Autor:
Emily Liang, Cecelia Perkins, Rong Lu, Hongliang Shi, Saša Dimitrijević, Gerard Hoehn, Justin Abuel, Cheryl Langford, Parveen Abidi, Lenn Fechter, William Shomali, Jason Gotlib
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S158
Autor:
Anandi Krishnan, Vanita Natu, James L. Zehnder, Jesse W. Rowley, Jason Gotlib, Lenn Fechter, Cecelia Perkins, Wenfei Du, Zhu Shen, Holden T. Maecker
Predicting disease progression remains a particularly challenging endeavor in chronic degenerative disorders and cancer, thus limiting early detection, risk stratification, and preventive interventions. Here, profiling the spectrum of chronic myelopr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70524bfe61b090e7c2cd61ba564693df
https://doi.org/10.1101/2021.03.12.435190
https://doi.org/10.1101/2021.03.12.435190
Autor:
Anandi Krishnan, Sumanth Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Jason Gotlib, James zehnder, Ramasamy Paulmurugan
Publikováno v:
Experimental Hematology. 111:S103
Publikováno v:
Clinical journal of oncology nursing. 23(6)
Background Acute myeloid leukemia (AML) and advanced systemic mastocytosis (SM) are clonal diseases of the blood. Prognoses for patients with FMS-like tyrosine kinase 3 (FLT3) mutation-positive AML and those with advanced SM are poor. In the United S
Autor:
Justin Abuel, William Shomali, Rong Lu, Cheryl Langford, Cecelia Perkins, Denise DeVore, Emily C. Liang, Jason Gotlib, Lenn Fechter, Parveen Abidi
Publikováno v:
Blood. 138:2567-2567
BACKGROUND: Systemic mastocytosis (SM) is characterized by the accumulation of neoplastic mast cells in various organs, including the bone marrow, liver, spleen, and gastrointestinal tract. Advanced SM (AdvSM) comprises 3 subtypes: aggressive SM (ASM
Autor:
Anandi Krishnan, Wenfei Du, Lenn Fechter, Jason Gotlib, Holden Maecker, Vanita Natu, Cecelia Perkins, Jesse Rowley, Zhu Shen, James Zehnder
Publikováno v:
Experimental Hematology. 100:S82